LLY

1,006.06

+1.27%↑

JNJ

209.91

+1.6%↑

ABBV

223.8

-0.55%↓

UNH

336.55

+2.68%↑

AZN

90.26

-1.28%↓

LLY

1,006.06

+1.27%↑

JNJ

209.91

+1.6%↑

ABBV

223.8

-0.55%↓

UNH

336.55

+2.68%↑

AZN

90.26

-1.28%↓

LLY

1,006.06

+1.27%↑

JNJ

209.91

+1.6%↑

ABBV

223.8

-0.55%↓

UNH

336.55

+2.68%↑

AZN

90.26

-1.28%↓

LLY

1,006.06

+1.27%↑

JNJ

209.91

+1.6%↑

ABBV

223.8

-0.55%↓

UNH

336.55

+2.68%↑

AZN

90.26

-1.28%↓

LLY

1,006.06

+1.27%↑

JNJ

209.91

+1.6%↑

ABBV

223.8

-0.55%↓

UNH

336.55

+2.68%↑

AZN

90.26

-1.28%↓

Home・Aktien・Crescent Biopharma Inc

C
Crescent Biopharma Inc

Geschlossen

BrancheGesundheitswesen

15.25 5.39

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

13.44

Max

15.32

Empfehlungen
By TipRanks
Empfehlungen	Starkes Kaufsignal
12-Monats-Prognose	+104.01% upside

Nachrichtenstimmung

By Acuity

67%

33%

341 / 374 Ranking in Healthcare

Crescent Biopharma Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

10. Dez. 2025, 22:02 UTC

Ergebnisse

Synopsys Sees Strong 2026 as Ansys Acquisition Boosts 4Q Revenue

10. Dez. 2025, 21:46 UTC

Ergebnisse

Adobe Expects Double-Digit Recurring Revenue Growth Next Year

10. Dez. 2025, 23:52 UTC

Akquisitionen, Fusionen, Übernahmen

Paramount Sends Letter to Warner Bros. Shareholders Saying Its Offer Is 'Superior' -- Barrons.com

10. Dez. 2025, 23:43 UTC

Market Talk

Nikkei May Rise After Fed Rate Cut -- Market Talk

10. Dez. 2025, 23:36 UTC

Market Talk

Gold Consolidates as Traders Digest FOMC Decision -- Market Talk

10. Dez. 2025, 23:20 UTC

Ergebnisse

Oracle Reports $16.1 Billion in Revenue, Narrowly Missing Forecasts -- 2nd Update

10. Dez. 2025, 23:15 UTC

Ergebnisse

Synopsys Targets Double-Digit Growth Following Ansys Acquisition -- Interview

10. Dez. 2025, 22:59 UTC

Market Talk

Ergebnisse

Akquisitionen, Fusionen, Übernahmen

Adobe Expects Semrush Deal to Bring in New Users -- Market Talk

10. Dez. 2025, 22:45 UTC

Market Talk

Coca-Cola's New CEO Pick Looks A Lot Like The Last One -- Market Talk

10. Dez. 2025, 22:40 UTC

Ergebnisse

Synopsys Stock Rises on Earnings Beat, Higher Guidance -- Barrons.com

10. Dez. 2025, 22:06 UTC

Akquisitionen, Fusionen, Übernahmen

Paramount Sends Letter to Warner Bros. Shareholders Saying Their Offer Is 'Superior' -- Barrons.com

10. Dez. 2025, 22:06 UTC

Ergebnisse

Oracle Reports Mixed Earnings. The Stock Is Falling. -- Barrons.com

10. Dez. 2025, 22:02 UTC

Ergebnisse

Synopsys Stock Rises on Earnings Beat, Higher Guidance -- Barrons.com

10. Dez. 2025, 22:00 UTC

Ergebnisse

Oracle Reports $16.1 Billion in Revenue, Narrowly Missing Forecasts -- Update

10. Dez. 2025, 21:53 UTC

Ergebnisse

Adobe Earnings Show 'Rapid Adoption' of AI Tools. The Stock Is Up. -- Barrons.com

10. Dez. 2025, 21:50 UTC

Akquisitionen, Fusionen, Übernahmen

Investors Bet That a Higher Bid for Warner Is Coming -- Update

10. Dez. 2025, 21:50 UTC

Market Talk

Ergebnisse

Akquisitionen, Fusionen, Übernahmen

Financial Services Roundup: Market Talk

10. Dez. 2025, 21:50 UTC

Market Talk

Health Care Roundup: Market Talk

10. Dez. 2025, 21:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

10. Dez. 2025, 21:45 UTC

Akquisitionen, Fusionen, Übernahmen

Paramount Sends Letter to Warner Bros. Shareholders Saying Their Offer Is 'Superior' -- Barrons.com

10. Dez. 2025, 21:33 UTC

Ergebnisse

Oracle Reports $16.1 Billion in Revenue, Narrowly Missing Forecasts -- WSJ

10. Dez. 2025, 21:32 UTC

Ergebnisse

Oracle Reports Mixed Earnings. The Stock Is Falling. -- Barrons.com

10. Dez. 2025, 21:28 UTC

Akquisitionen, Fusionen, Übernahmen

Sverica Capital Management Announces Sale of Coastal Cloud Holdings to Tata Consultancy Services for $700M

10. Dez. 2025, 21:25 UTC

Ergebnisse

Adobe Earnings Show 'Rapid Adoption' of AI Tools. The Stock Is Up. -- Barrons.com

10. Dez. 2025, 21:18 UTC

Akquisitionen, Fusionen, Übernahmen

Paramount Skydance: Company Has Air Tight Financing to Deliver on Warner Bros. Offer >PSKY

10. Dez. 2025, 21:16 UTC

Ergebnisse

Oracle Reports Mixed Earnings. The Stock is Falling. -- Barrons.com

10. Dez. 2025, 21:15 UTC

Akquisitionen, Fusionen, Übernahmen

Paramount Skydance: Public Offer for Warner Bros. Delivers Superior Value, Faster, More Certain Path to Completion

10. Dez. 2025, 21:15 UTC

Ergebnisse

Oracle: 'Sold Ampere Because We No Longer Think It Is Strategic for Us to Continue Designing, Manufacturing and Using Our Own Chips in Our Cloud Datacenters' >ORCL

10. Dez. 2025, 21:14 UTC

Ergebnisse

Oracle 2Q Non-GAAP Operating Income Was $6.7 B >ORCL

10. Dez. 2025, 21:14 UTC

Ergebnisse

Oracle 2Q GAAP Operating Income Was $4.7 B >ORCL

Peer-Vergleich

Kursveränderung

Crescent Biopharma Inc Prognose

Kursziel

By TipRanks

104.01% Vorteil

12-Monats-Prognose

Durchschnitt 28.5 USD 104.01%

Hoch 35 USD

Tief 22 USD

Basierend auf 5 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Crescent Biopharma Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

5 ratings

Buy

Halten

Sell

Basierend auf 5 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Crescent Biopharma Inc – Dist abgegeben haben.

Stimmung

By Acuity

341 / 374 Ranking in Gesundheitswesen

Finanzen

Andere Aktien aus dem Sektor

LLY

Eli Lilly and Co.

1,006.06

↑ +1.27%

JNJ

Johnson and Johnson

209.91

↑ +1.6%

ABBV

AbbVie Inc

223.8

↓-0.55%

UNH

UnitedHealth Group Inc

336.55

↑ +2.68%

AZN

AstraZeneca PLC ADR

90.26

↓-1.28%

C Crescent Biopharma Inc

Übersicht

Veränderung der Aktienkurses

Empfehlungen

Nachrichtenstimmung

Crescent Biopharma Inc Chart

Ähnliche Nachrichten

Peer-Vergleich

Crescent Biopharma Inc Prognose

Kursziel

Rating-Konsens

Stimmung

Finanzen

Andere Aktien aus dem Sektor

C
Crescent Biopharma Inc